ESAOTE LAUNCHED MyLab™Eight Platform: NEW FLAGSHIP PRODUCT IN MyLab™ ULTRASOUND FAMILY
Esaote, which is one of the world leaders in the manufacture of diagnostic ultrasound systems and probes and has been on the market for more than 30 years, launched MyLab™Eight Platform, the flagship platform in its Ultrasound portfolio. Esaote MyLab™Eight eXP/MyLab™Eight Ultrasound systems define a new standard in Image Quality for confident diagnosis. MyLab™Eight platform is the culmination of Esaote’s commitment to R&D in order to meet the increasing demands of modern healthcare in terms of outstanding image quality and ease of use.
Confident Diagnosis - MyLab™Eight platform incorporates the new eMPowered Engine to optimize high-density single crystal transducers to enable images to be captured deeper in the body with unprecedented quality for difficult-to-scan patients.
The new WideView visualization technology offers sharp diagnostic image clarity with enhanced spatial and contrast resolution.
With high-frequency imaging, advanced hemodynamic evaluation tools such as XFlow and HD CFM, and complete portfolio of probes, Esaote offers solutions covering Radiology, Cardiovascular, Obstetrics and Gynecology as well as Interventional and Surgery.
Productivity and Comfort - Esaote’s focus on the prevention of work-related musculoskeletal disorders runs through a new approach to design: from award-winning appleprobe transducers to MyLabRemote, the remote system user interface App that allows MyLab™Eight platform to be controlled via smartphone or tablet. The touchscreen-based workflow offers intuitive commands so that the systems can be easily operated in any scanning condition.